Viral Polymerase Structure Overview

Principles

Definition

Viral polymerase structure is a core area of investigation within structural virology and molecular biology dedicated to determining and analyzing the three-dimensional atomic arrangement of viral enzymes responsible for synthesizing viral nucleic acids. This research investigates the relationship between the enzyme's architecture, its catalytic mechanism, interactions with substrates and inhibitors, and conformational dynamics, providing fundamental insights crucial for understanding viral replication processes and informing the rational design of antiviral therapeutics targeting these essential enzymes.

Ontological type

Key Structural Motifs

Inhibitor Binding Sites

Conformational Dynamics

Key developments

Key Figures

Enzymology and RNA End-Structures era

David Baltimore[1], anchored at Harvard University[3] and the Massachusetts Institute of Technology[4] during this era, helped frame the study of modular polymerase architectures and RNA end-structures. His key contributions include the covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus [7], the discovery that the 5'-terminal structure of poliovirus polyribosomal RNA is pUp [9], and the related implications for retroviral initiation from the cloned Moloney murine leukemia virus DNA molecule [8], collectively highlighting initiation modes and interfaces with polymerase modules that shaped experimental reconstitution and mutagenesis paradigms in this era. J Hurwitz[2], associated with Rockefeller University[5] and the Albert Einstein College of Medicine[6] during this era, contributed to foundational understanding of how polymerases coordinate replication with accessory factors. Key contributions include the role of DNA polymerase alpha and DNA primase in simian virus 40 DNA replication in vitro [10], the separation of the adenovirus terminal protein precursor from its associated DNA polymerase and its role in initiation of adenovirus DNA replication [11], and the purification and properties of vaccinia virus DNA-dependent RNA polymerase [12], illustrating how polymerase complexes interface with initiation proteins and control replication fidelity in this era.

Domain Architecture and Holoenzymes era

Raffaele De Francesco [1] is associated with The University of Texas Southwestern Medical Center [3] and United States Military Academy [4] during the Domain Architecture and Holoenzymes era (1987-2008). He identified and characterized the RNA-dependent RNA polymerase of hepatitis C virus [7], and elucidated its crystal structure [8], and demonstrated that 2′-modified nucleoside analogs inhibit RNA replication [9]. Ralf Bartenschlager [2] is affiliated with Park University [5] and Heidelberg University [6] during this era. His key contribution is the 1997 Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity [10], which clarified NS5B function and informed inhibitor mapping for this era.

Cross‑Virus RdRp Structural Paradigm era

Zihe Rao [1], with affiliations at Wageningen University & Research [3] and Nankai University [4], emerges as a central figure in establishing the cross-virus RdRp structural paradigm. Her key contributions include the structural basis for RNA replication by the SARS-CoV-2 polymerase [6], the crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site [7], and the structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target [8], collectively clarifying the palm–fingers–thumb core and interdomain networks that drive processivity and inform inhibitor design. Zhiyong Lou [2], with affiliations to Nankai University [4] and Tsinghua University [5], contributed to these RdRp-structure works including the SARS-CoV-2 polymerase [6], the avian influenza PAN polymerase [7], and the 2019-nCoV RdRP [8], helping shape the structural paradigm. His contributions, as documented in [6], [7], and [8], helped illuminate conserved active-site interactions and cofactor interfaces that enable structure-guided antiviral strategies and resistance monitoring across viruses.